Publications
Showing entries 21 - 40 out of 108
2022
Baier D, Schönhacker-Alte B, Rusz M, Pirker C, Mohr T, Mendrina T et al. The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation. Pharmaceutics. 2022 Jan 20;14(2):238. doi: 10.3390/pharmaceutics14020238
2021
Ozenil M, Skos L, Roller A, Gajic N, Holzer W, Spreitzer H et al. Unexpected scaffold rearrangement product of pirenzepine found in commercial samples. Scientific Reports. 2021 Dec 3;11(1):23397. doi: 10.1038/s41598-021-02732-y
Brunmair J, Gotsmy M, Niederstaetter L, Neuditschko B, Bileck A, Slany A et al. Finger sweat analysis enables short interval metabolic biomonitoring in humans. Nature Communications. 2021 Oct 13;12(1):5993. doi: 10.1038/s41467-021-26245-4
Neuditschko B, Leibetseder M, Brunmair J, Hagn G, Skos L, Gerner MC et al. Epithelial Cell Line Derived from Endometriotic Lesion Mimics Macrophage Nervous Mechanism of Pain Generation on Proteome and Metabolome Levels. Biomolecules. 2021 Aug 17;11(8):1230. doi: 10.3390/biom11081230
Babak MV, Chong KR, Rapta P, Zannikou M, Tang HM, Reichert L et al. Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin Prodrugs. Angewandte Chemie (International Edition). 2021 Jun 7;60(24):13405-13413. doi: 10.1002/anie.202102266
Lin YS, Weibel J, Landolt HP, Santini F, Meyer M, Brunmair J et al. Daily Caffeine Intake Induces Concentration-Dependent Medial Temporal Plasticity in Humans: A Multimodal Double-Blind Randomized Controlled Trial. Cerebral Cortex. 2021 Jun;31(6):3096-3106. doi: 10.1093/cercor/bhab005
Brunmair J, Bileck A, Stimpfl T, Raible F, Del Favero G, Meier-Menches SM et al. Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predictive, preventive and personalised medicine. The EPMA journal. 2021 Jun;12:141–153. doi: 10.1007/s13167-021-00241-6
Neuditschko B, Legin AA, Baier D, Schintlmeister A, Reipert S, Wagner M et al. Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD-100/KP1339 in the Endoplasmic Reticulum. Angewandte Chemie (International Edition). 2021 Mar 1;60(10):5063-5068. doi: 10.1002/anie.202015962
Voloshin YZ, Dudkin SV, Belova SA, Gherca D, Samohvalov D, Manta CM et al. Spectroelectrochemical Properties and Catalytic Activity in Cyclohexane Oxidation of the Hybrid Zr/Hf-Phthalocyaninate-Capped Nickel(II) and Iron(II) tris-Pyridineoximates and Their Precursors. Molecules. 2021 Jan;26(2):336. doi: 10.3390/molecules26020336
2020
Meier-Menches SM, Neuditschko B, Zappe K, Schaier M, Gerner MC, Schmetterer KG et al. An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells. Chemistry: A European Journal. 2020 Dec 1;26(67):15528-15537. doi: 10.1002/chem.202003495
Wernitznig D, Meier-Menches SM, Cseh K, Theiner S, Wenisch D, Schweikert A et al. Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids. Metallomics. 2020 Dec 1;12(12):2121-2133. doi: 10.1039/d0mt00227e
Losytskyy M, Chornenka N, Vakarov S, Meier-Menches SM, Gerner C, Potocki S et al. Sensing of Proteins by ICD Response of Iron(II) Clathrochelates Functionalized by Carboxyalkylsulfide Groups. Biomolecules. 2020 Dec;10(12):1-16. 1602. doi: 10.3390/biom10121602
Baier DS, Schönhacker-Alte B, Pirker C, Englinger B, Mohr T, Meier-Menches S et al. Lipid metabolism as target and modulator of KP1339 anticancer activity. Cancer Research. 2020 Aug;80(16):Meeting Abstract: 1839 . doi: 10.1158/1538-7445.AM2020-1839
Thomas SR, Bonsignore R, Sanchez Escudero J, Meier-Menches SM, Brown CM, Wolf MO et al. Exploring the Chemoselectivity towards Cysteine Arylation by Cyclometallated Au(III)Compounds: New Mechanistic Insights. ChemBioChem: a european journal of chemical biology. 2020 Jul 8;21(21):3071-3076. doi: 10.1002/cbic.202000262
Meier-Menches SM, Casini A. Design Strategies and Medicinal Applications of Metal-Peptidic Bioconjugates. Bioconjugate Chemistry. 2020 May 20;31(5):1279-1288. doi: 10.1021/acs.bioconjchem.0c00152
Mokesch S, Cseh K, Geisler H, Hejl M, Klose MHM, Roller A et al. Investigations on the Anticancer Potential of Benzothiazole-Based Metallacycles. Frontiers in Chemistry. 2020 Apr 3;8:209. doi: 10.3389/fchem.2020.00209
Englinger B, Laemmerer A, Moser P, Kallus S, Roehrl C, Pirker C et al. Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib. International Journal of Cancer. 2020 Mar 2;147(6):1680-1693. doi: 10.1002/ijc.32924
2019
Kreutz D, Gerner C, Meier-Menches SM. Enabling Methods to Elucidate the Effects of Metal-based Anticancer Agents. In Casini A, Vessieres A, Meier-Menches SM, editors, Metal-based Anticancer Agents . Royal Society of Chemistry. 2019. p. 246-270. (RSC Metallobiology; No. 14, Vol. 2019-January). doi: 10.1039/9781788016452-00246
van Dijk F, Teekamp N, Post E, Schuppan D, Kim YO, Zuidema J et al. The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor. Journal of Controlled Release. 2019 Feb 28;296:250-257. doi: 10.1016/j.jconrel.2018.12.039
Meier-Menches SM, Zappe K, Bileck A, Kreutz D, Tahir A, Cichna-Markl M et al. Time-dependent shotgun proteomics revealed distinct effects of an organoruthenium prodrug and its activation product on colon carcinoma cells. Metallomics: integrated biometal science. 2019 Jan 1;11(1):118-127. doi: 10.1039/c8mt00152a